The Neurological Gene Therapy Compendium (Paperback)

Paperback. The field of neurology is undergoing a profound transformation driven by rapid advances in molecular medicine, genetic engineering, and targeted therapeutic design. At the center of this evolution lies gene therapy-a discipline that redefines disease treatment not by managing symptoms, but by directly addressing the underlying genetic and molecular causes of neurological disorders.Neurological diseases, ranging from rare monogenic disorders to complex neurodegenerative conditions, have long posed significant therapeutic challenges due to the intricate architecture of the central and peripheral nervous systems, the presence of biological barriers such as the blood-brain barrier, and the limited regenerative capacity of neural tissue. Traditional pharmacological interventions often provide only partial symptomatic relief, leaving the root causes of disease progression unaddressed. In contrast, gene-based therapies introduce a paradigm shift: they enable the modulation, replacement, silencing, or editing of specific genetic sequences to restore normal cellular function or counteract pathological processes at their source.This compendium situates itself within the rapidly expanding landscape of neurological gene therapy technologies, including adeno-associated virus (AAV) vector systems, lentiviral platforms, antisense oligonucleotides (ASOs), RNA interference strategies, and emerging genome-editing tools such as CRISPR-based systems. Each of these modalities represents a distinct yet interconnected approach to reshaping gene expression in the nervous system. Together, they form a versatile therapeutic toolkit capable of targeting diverse pathological mechanisms such as loss-of-function mutations, toxic gain-of-function protein accumulation, aberrant splicing, and disrupted neuronal signaling pathways.Beyond molecular innovation, the text emphasizes the translational journey from bench to bedside. It examines how preclinical discoveries are refined through vector optimization, delivery route engineering, and safety profiling to achieve clinically viable therapies. Landmark successes in conditions such as spinal muscular atrophy and inherited retinal dystrophies illustrate the real-world potential of gene therapy to alter disease trajectories once considered irreversible. At the same time, ongoing clinical trials in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and other neurodegenerative disorders underscore both the promise and the complexity of extending these therapies to multifactorial conditions.Importantly, this work also prioritizes the patient-centered dimension of neurological gene therapy. It recognizes that therapeutic success extends beyond molecular correction to include quality of life, functional independence, long-term safety, accessibility, and ethical considerations surrounding genetic intervention. Issues such as immune responses to viral vectors, durability of gene expression, equitable access to high-cost therapies, and long-term monitoring of treated patients are critically examined within the broader context of clinical decision-making.Ultimately, The Neurological Gene Therapy Compendium positions itself as both a scientific reference and a conceptual guide for understanding one of the most promising frontiers in modern medicine. By integrating molecular mechanisms with therapeutic applications and human-centered outcomes, it offers a unified perspective on how gene therapy is reshaping the future of neurological care-moving from experimental innovation toward a new era of precision, durability, and restorative potential in brain and nervous system health. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. …